AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted KnockoffInvestors Business Daily • 01/31/23
6 Jefferies Franchise List ‘Strong Buy' Stocks With Big Upside and Dependable Dividends24/7 Wall Street • 01/31/23
AMJEVITA™ (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATESPRNewsWire • 01/31/23
HORIZON THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Horizon Therapeutics Public Limited Company - HZNPBusiness Wire • 01/25/23
AMGEN AND BIOLABS LA AT THE LUNDQUIST INSTITUTE ANNOUNCE NAMMI THERAPEUTICS TO RECEIVE THE THIRD AMGEN GOLDEN TICKETPRNewsWire • 01/06/23